Australia Markets closed

Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
9.6900.000 (0.00%)
At close: 04:08PM HKT
Full screen
Previous close9.690
Open9.690
Bid9.510 x N/A
Ask9.690 x N/A
Day's range9.500 - 9.750
52-week range7.200 - 14.660
Volume201,000
Avg. volume264,704
Market cap3.173B
Beta (5Y monthly)0.39
PE ratio (TTM)N/A
EPS (TTM)-0.260
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.53
  • PR Newswire

    Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability

    Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market in China, announced its annual financial results for 2023. The report underlines a year of remarkable revenue growth and profitability, with revenues soaring to 530 million RMB ($75 million), marking a 58.0% YOY increase. The gross profit increased 52.4% to 380 million RMB ($54 million), with the company maintaining a solid gross margin of 72.9%. Wit

  • PR Newswire

    Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions

    Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in China, today announced a new strategic partnership with Avinger, a commercial-stage medical device company developing and marketing the first and only intra-vascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease. This partnership includes an exclusive right to Zylox-Tonbridge to localize, manufacture, and commercialize the

  • PR Newswire

    Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE

    Zylox-Tonbridge (2190.HK), a medical device company specializing in peripheral and neurovascular interventions, proudly announces the recent marketing approvals granted by the Ministry of Health and Prevention in the United Arab Emirates for five of its advanced products. These include the ZENFluxion™ Drug-coated PTA Balloon Catheter, ZENFlow™ HP PTA Balloon Catheter, ZENFlow™ PTA Balloon Catheter, ZENFlex™ Peripheral Stent System, and ZENFLEX Pro™ Peripheral Drug-eluting Stent System. This mile